Diagnosis of Men-I Syndrome on 68Ga-Dotanoc PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate

International Journal of Endocrinology and Metabolism - Netherlands
doi 10.5812/ijem.4313
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Kowsar Medical Institute

Related search

68Ga-Dotatate PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients With Well-Differentiated Neuroendocrine Tumors

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2010English

Meningiomas: A Comparative Study of 68Ga-Dotatoc, 68Ga-Dotanoc and 68Ga-Dotatate for Molecular Imaging in Mice

PLoS ONE
Multidisciplinary
2014English

A Dual Tracer 68Ga-Dotanoc PET/CT and 18f-FDG PET/CT Pilot Study for Detection of Cardiac Sarcoidosis

EJNMMI Research
Nuclear MedicineRadiologyImaging
2016English

Practıcal Aspects of 68Ga-Labelled Dota-Peptides for Peptide-Receptor Radionuclide Therapy

Journal of Engineering Technology and Applied Sciences
2016English

A Comparison of 68Ga-Dotatate and 18f-FDG PET/CT in Pulmonary Neuroendocrine Tumors

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

DNA Damage in Blood Lymphocytes in Patients After 177Lu Peptide Receptor Radionuclide Therapy

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2015English

Neuroendocrine Tumor Recurrence: Diagnosis With68Ga-Dotatate PET/CT

Radiology
Nuclear MedicineRadiologyImaging
2013English

Peptide Receptor Radionuclide Therapy

Best Practice and Research in Clinical Gastroenterology
Gastroenterology
2005English

Peptide Receptor Radionuclide Therapy

2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy